148 related articles for article (PubMed ID: 19877536)
41. [Creutzfeldt-Jakob disease in Austria].
Hainfellner JA; Jellinger K; Diringer H; Guentchev M; Kleinert R; Pilz P; Maier H; Budka H
Wien Klin Wochenschr; 1996 Dec; 108(23):759-63. PubMed ID: 9092208
[TBL] [Abstract][Full Text] [Related]
42. Creutzfeldt-Jakob Disease in South West Sydney 2014-2020: An Unusually High Incidence of a Rare Disease.
Goire N; Edwards L; Thomas P; Bhaskar SMM; Cordato D; Buckland ME; Beran RG
Neuroepidemiology; 2022; 56(1):59-65. PubMed ID: 34763340
[TBL] [Abstract][Full Text] [Related]
43. Surveillance for Creutzfeldt-Jakob disease--United States.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(31):665-8. PubMed ID: 8769655
[TBL] [Abstract][Full Text] [Related]
44. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2016.
Klug GM; Sarros S; Stehmann C; Simpson M; McLean C; Masters CL; Collins SJ
Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626302
[TBL] [Abstract][Full Text] [Related]
45. Creutzfeldt-Jakob disease cluster in an Australian rural city.
Collins S; Boyd A; Fletcher A; Kaldor J; Hill A; Farish S; McLean C; Ansari Z; Smith M; Masters CL
Ann Neurol; 2002 Jul; 52(1):115-8. PubMed ID: 12112059
[TBL] [Abstract][Full Text] [Related]
46. [Epidemiology and surveillance system of prion disease in Japan].
Noguchi-Shinohara M; Hamaguchi T; Yamada M
Nihon Rinsho; 2007 Aug; 65(8):1379-83. PubMed ID: 17695272
[TBL] [Abstract][Full Text] [Related]
47. High incidence of genetic human transmissible spongiform encephalopathies in Italy.
Ladogana A; Puopolo M; Poleggi A; Almonti S; Mellina V; Equestre M; Pocchiari M
Neurology; 2005 May; 64(9):1592-7. PubMed ID: 15883322
[TBL] [Abstract][Full Text] [Related]
48. [Non-familial Creutzfeldt-Jakob disease: a study of 53 cases].
Giraud P; Perret-Liaudet A; Biacabe AG; Deslys JP; Laplanche JL; Chazot G; Kop N
Rev Neurol (Paris); 2000 Jul; 156(6-7):616-21. PubMed ID: 10891795
[TBL] [Abstract][Full Text] [Related]
49. Human prion disease surveillance in Spain, 1993-2018: an overview.
De Pedro-Cuesta J; Almazán-Isla J; Tejedor-Romero L; Ruiz-Tovar M; Avellanal F; Rábano A; Calero M; García López FJ;
Prion; 2021 Dec; 15(1):94-106. PubMed ID: 34120571
[TBL] [Abstract][Full Text] [Related]
50. [Transmissible spongiform encephalopathies--illnesses in the human].
Budka H
Wien Med Wochenschr; 1998; 148(4):86-95. PubMed ID: 9611348
[TBL] [Abstract][Full Text] [Related]
51. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.
Holman RC; Khan AS; Belay ED; Schonberger LB
Emerg Infect Dis; 1996; 2(4):333-7. PubMed ID: 8969250
[TBL] [Abstract][Full Text] [Related]
52. [Epidemiology and clinical symptomatology of Creutzfeldt-Jakob disease].
Mollenhauer B; Zerr I; Ruge D; Krause G; Mehnert WH; Kretzschmar HA; Poser S
Dtsch Med Wochenschr; 2002 Feb; 127(7):312-7. PubMed ID: 11845386
[TBL] [Abstract][Full Text] [Related]
53. Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998-2012.
Litzroth A; Cras P; De Vil B; Quoilin S
BMC Neurol; 2015 Dec; 15():250. PubMed ID: 26630984
[TBL] [Abstract][Full Text] [Related]
54. Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993-2000.
Puopolo M; Ladogana A; Almonti S; Daude N; Bevivino S; Petraroli R; Poleggi A; Quanguo L; Pocchiari M
J Clin Epidemiol; 2003 May; 56(5):494-9. PubMed ID: 12812825
[TBL] [Abstract][Full Text] [Related]
55. Creutzfeldt-Jakob disease mortality in Italy, 1982-1996.
Arpino C; Conti S; Masocco M; Toccaceli V; Ladogana A; D'Alessandro M; Pocchiari M
Neuroepidemiology; 1999; 18(2):92-100. PubMed ID: 10023132
[TBL] [Abstract][Full Text] [Related]
56. [Creutzfeldt-Jakob syndrome in the county of Storstrom during the period 1990-1999. Was there a significant accumulation of cases?].
Christoffersen BR; Jansen J
Ugeskr Laeger; 2001 Nov; 163(45):6275-9. PubMed ID: 11723687
[TBL] [Abstract][Full Text] [Related]
57. Barriers to Creutzfeldt-Jakob disease autopsies, California.
Louie JK; Gavali SS; Belay ED; Trevejo R; Hammond LH; Schonberger LB; Vugia DJ
Emerg Infect Dis; 2004 Sep; 10(9):1677-80. PubMed ID: 15498177
[TBL] [Abstract][Full Text] [Related]
58. Creutzfeldt-Jakob disease in Mexico.
Velásquez-Pérez L; Rembao-Bojorquez D; Guevara J; Guadarrama-Torres RM; Trejo-Contreras A
Neuropathology; 2007 Oct; 27(5):419-28. PubMed ID: 18018474
[TBL] [Abstract][Full Text] [Related]
59. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic evaluation for Creutzfeldt-Jakob disease in Massachusetts, 1991-2001.
Jara M; John B; Kreindel S; Wilk-Rivard E; DeMaria A
Clin Infect Dis; 2005 Sep; 41(6):829-33. PubMed ID: 16107981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
